Global Hepatic Encephalopathy Market is estimated to be valued at US$ 403.3 million in 2023 and is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030). Increase in product launches by key market players is expected to drive the market growth during the forecast period. Moreover, an increase in prevalence of disease such as jaundice and others is also expected to drive the market growth.
Figure 1. Global Hepatic Encephalopathy Market Share (%), By Drug Class, 2023
Based on Drug Class, the market is segmented into hepatic encephalopathy, antibiotics, laxatives, l-ornithine l-aspartate and others. Out of which, the antibiotics is segment is expected to dominate the global hepatic encephalopathy market during the forecast period owing to the increasing product launches and approvals by the major market players.
Hepatic Encephalopathy Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients